gamma-valerolactone has been researched along with flavan-3-ol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bidault, G; Brindani, N; Carobbio, S; Curti, C; Del Rio, D; Mele, L; Mena, P; Rodriguez-Cuenca, S; Vacca, M; Vidal-Puig, A; Zanotti, I | 1 |
| Angelino, D; Bresciani, L; Brighenti, F; Brindani, N; Calani, L; Clifford, MN; Crozier, A; Curti, C; Del Rio, D; Gill, CIR; Llorach, R; Ludwig, IA; Mena, P; Pereira-Caro, G | 1 |
| Angelino, D; Bladé, C; Brighenti, F; Brindani, N; Brito, MA; Carregosa, D; Curti, C; Davis, CD; Del Bas, JM; Del Rio, D; Domenech-Coca, C; Figueira, I; Jang, S; Kim, KS; Lakshman, S; Mena, P; Molokin, A; Santos, CND; Savi, M; Solano-Aguilar, GI; Stilli, D; Urban, JF | 1 |
| Curti, C; Del Rio, D; Gatto, P; Mattivi, F; Mena, P; Pancher, M; Quattrone, A; Rubert, J; Sidarovich, V | 1 |
| Angelino, D; Boyd, K; Caffrey, A; Clements, M; Cunningham, C; Del Rio, D; Gill, CI; Hoey, L; Jarrett, H; Laird, E; McCarroll, K; McNulty, H; Mena, P; Molloy, AM; Moore, AJ; Moore, K; Mullen, B; Pucci, B; Rosi, A; Strain, JJ; Ward, M | 1 |
| Bindon, K; Bondonno, CP; Bondonno, NP; Christophersen, CT; Croft, K; Del Rio, D; Genoni, A; Hodgson, JM; Kay, C; Mena, P; Murray, K; Parmenter, BH; Shinde, S | 1 |
| Crozier, A; Ensunsa, JL; Fong, RY; Kuhnle, GGC; Momma, TY; Ottaviani, JI; Schroeter, H | 1 |
1 review(s) available for gamma-valerolactone and flavan-3-ol
| Article | Year |
|---|---|
Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity.
Topics: Animals; Biological Availability; Colon; Diet; Feces; Flavonoids; Humans; Lactones; Metabolomics; Molecular Structure; Pentanoic Acids | 2019 |
1 trial(s) available for gamma-valerolactone and flavan-3-ol
| Article | Year |
|---|---|
Performance of Urinary Phenyl-γ-Valerolactones as Biomarkers of Dietary Flavan-3-ol Exposure.
Topics: Biomarkers; Catechin; Flavonoids; Glucuronides; Humans; Sulfates; Tea | 2023 |
5 other study(ies) available for gamma-valerolactone and flavan-3-ol
| Article | Year |
|---|---|
Phenyl-γ-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function.
Topics: Adipocytes, Brown; Animals; Cell Differentiation; Colon; Cytoprotection; Flavonoids; HEK293 Cells; Humans; Lactones; Mice; Mice, Inbred C57BL; Oxidative Stress; PPAR gamma | 2017 |
5-(Hydroxyphenyl)-γ-Valerolactone-Sulfate, a Key Microbial Metabolite of Flavan-3-ols, Is Able to Reach the Brain: Evidence from Different in
Topics: Animals; Blood-Brain Barrier; Brain; Cacao; Endothelial Cells; Flavonoids; Humans; Lactones; Models, Theoretical; Pentanoic Acids; Permeability; Plant Extracts; Polyphenols; Rats; Sulfates; Swine; Vitis | 2019 |
A Screening of Native (Poly)phenols and Gut-Related Metabolites on 3D HCT116 Spheroids Reveals Gut Health Benefits of a Flavan-3-ol Metabolite.
Topics: Flavonoids; Gastrointestinal Microbiome; Phenols; Polyphenols | 2022 |
Association of dietary flavan-3-ol intakes with plasma phenyl-γ-valerolactones: analysis from the TUDA cohort of healthy older adults.
Topics: Aged; Catechin; Eating; Flavonoids; Humans; Phenols; Polyphenols; Proanthocyanidins | 2023 |
5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone Is a Substrate for Human Paraoxonase: A Novel Pathway in Flavan-3-ol Metabolism.
Topics: Aryldialkylphosphatase; Flavonoids; Humans; Lactones; Male | 2023 |